Status:
UNKNOWN
Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder
Lead Sponsor:
Xijing Hospital
Conditions:
Neurofeedback
Attention Deficit Hyperactivity Disorder (ADHD)
Eligibility:
All Genders
6-12 years
Phase:
NA
Brief Summary
To observe the clinical efficacy and mechanism of functional near-infrared spectroscopy imaging neurofeedback therapy for attention deficit and hyperactivity disorder.
Detailed Description
In this study, a parallel controlled study will be conducted to recruit 60 patients with ADHD, 30 patients in the fNIRS group and 30 patients in the drug group. At the same time, 30 healthy controls w...
Eligibility Criteria
Inclusion
- For ADHD patients:
- diagnosed with TD, according to the American Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5);
- aged 6-12;
- right handed;
Exclusion
- full-scale intelligence quotient below 80(measured by Wechsler Intelligence Scale for Children，WISC)
- medical or neurological disorders, psychiatric disorders other than oppositional defiant disorder
- current participation in a psychotherapeutic treatment
Key Trial Info
Start Date :
January 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04065906
Start Date
January 15 2019
End Date
December 31 2020
Last Update
August 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Psychiatry, Xijing Hospital, The Air Force Medical University
Xi'an, Shaanxi, China